2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine

Catalog No. :
ACPUJK896
CAS No. :
1192570-20-9
Molecular Formula :
C11H15F3N4O
Molecular Weight :
276.26

IUPAC Name:2-morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethan-1-amine

2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$359.00Login to see priceInquiryInquiry
1g98%$898.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine
IUPAC Name2-morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethan-1-amine
MDL No.MFCD16877055
Molecular FormulaC11H15F3N4O
Molecular Weight276.26
SMILESFC(C1=NC=C(C(N2CCOCC2)CN)C=N1)(F)F
InChI KeyANPTUIJETQUQQQ-UHFFFAOYSA-N
Synonym2-morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine;beta-[2-(Trifluoromethyl)-5-pyrimidinyl]-4-morpholineethanamine;2-(morpholin-4-yl)-2-[2-(trifluoromethyl)pyrimidin-5-yl]ethan-1-amine;4-Morpholineethanamine, β-[2-(trifluoromethyl)-5-pyrimidinyl]-;2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethan-1-amine;2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine?New
CAS No.1192570-20-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPUJK896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPUJK896 route product structure diagram
    ACPUJK8961192570-20-9
Inquiry

2. ACPUJK896 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPUJK896 route product structure diagram
    ACPUJK8961192570-20-9
Inquiry

Comments (0)